Nektar Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results
Go back to Nektar Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 60.97 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.97 | 52 Week High | $19.98 | |||
| Open | $60.97 | 52 Week Low | $10.52 | |||
| Day High | $60.97 | P/E | N/A | |||
| Day Low | $60.97 | EPS | $-1.45 | |||
| Volume | 616 | |||||
